SEC Form D filing

Athos Therapeutics, Inc.

Biotech · Series B · Regulation D 506(b) · CA · Filed May 15, 2026

Offering amount: $20.0M
Exemption: Reg D 506(b)
Issuer state: CA
Filing date: May 15, 2026
Signature date: May 14, 2026
CIK: 0001885079

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Sector: Biotech Month: May 2026 Stage and month: Series B

Summary

Auto-generated

Athos Therapeutics is a therapeutic company; $20M offering aligns with series-b stage.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

View on SEC EDGAR →Get alerts for filings like this →

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.